Quest Diagnostics Incorporated (DGX) Stake Increased by Investec Asset Management Ltd

Advertisement

Quest Diagnostics Incorporated (NYSE:DGX).

Investec Asset Management Ltd reports that it raised its ownership in Quest Diagnostics Incorporated by 186,477 shares as of the end of the last quarter. Its position was valued at $242,182,000 an increase of $46,568,000 as of the end of the quarter.

These firms have also modified their investment in DGX. Financial Advantage, Inc. cut its ownership by selling 575 shares a decrease of 1.9% from 03/31/2017 to 06/30/2017. Financial Advantage, Inc. owns 29,782 shares valued at $3,310,000. The value of the position overall is up by 11.0%. As of quarter end Amalgamated Bank had acquired 5,521 shares growing its holdings by 55.8%. The value in dollars went from $972,000 to $1,714,000 a change of $742,000 quarter over quarter.

As of the end of the quarter Investec Asset Management North America, Inc. had bought a total of 966 shares growing its stake by 7.0%. The value of the total investment in Quest Diagnostics Incorporated increased from $1,351,000 to $1,637,000 a change of 21.2% quarter to quarter.

August 10 investment analysts at Morgan Stanley left the company rating at “Underweight” and raised the price target from $51.00 to $92.00. On July 25 the company was changed to a “Buy” according to a Bank of America report which was a boost from the previous “Underperform” rating.

Argus issued its first research report on the stock with an initial rating of “Hold”.

The company is so far trading down from yesterday’s close of $106.5. Additionally Quest Diagnostics Incorporated announced a dividend for shareholders which was paid on Monday the 24th of July 2017. The dividend payment was $0.450 per share for the quarter which comes to $1.80 on an annualized basis. The dividend yield was $1.69. The ex-dividend date was Thursday the 6th of July 2017.

The stock last traded at $105.61 which is marginally lower than the 50 day moving average which is $108.92 and which is just over the 200 day moving average of $102.93. The 50 day moving average was down by -3.04% and the 200 day average was up $2.68.

Quest Diagnostics Incorporated’s P/E ratio is 21.28 and the market cap is 14.41B. In the last earnings report the EPS was $4.96 and is expected to be $5.70 for the current year with 136,405,000 shares now outstanding. Next quarter’s EPS is expected be $1.38 and the next full year EPS is projected to be $5.95.